%20--%3e%3c!DOCTYPE%20svg%20PUBLIC%20'-//W3C//DTD%20SVG%201.1//EN'%20'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'%20[%20%3c!ENTITY%20st0%20'fill:%23267E9A;'%3e%3c!ENTITY%20st1%20'fill:%2378C9DA;'%3e%3c!ENTITY%20st2%20'fill:%23FFFFFF;'%3e%3c!ENTITY%20st3%20'fill:%23085580;'%3e%3c!ENTITY%20st4%20'fill:%2386C34A;'%3e%3c!ENTITY%20st5%20'fill:%232FBBCC;'%3e%3c!ENTITY%20st6%20'fill:%234C6F90;'%3e%3c!ENTITY%20st7%20'fill:%23194670;'%3e%3c!ENTITY%20st8%20'fill:%2307557E;'%3e%3c!ENTITY%20st9%20'fill:%23516E89;'%3e%20]%3e%3csvg%20version='1.1'%20id='Layer_1'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%2032%2032'%20style='enable-background:new%200%200%2032%2032;'%20xml:space='preserve'%3e%3cg%3e%3cg%3e%3crect%20x='10.3'%20y='14'%20style='&st5;'%20width='5'%20height='4.4'/%3e%3crect%20x='10.3'%20y='12'%20style='&st5;'%20width='11.4'%20height='1'/%3e%3crect%20x='16.4'%20y='14'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='15.8'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='17.5'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='19.3'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='10.3'%20y='19.3'%20style='&st5;'%20width='5'%20height='0.9'/%3e%3cg%3e%3cpath%20style='&st5;'%20d='M22.6,22.3H9.4c-0.6,0-1.2-0.5-1.2-1.2v-10c0-0.6,0.5-1.2,1.2-1.2h13.1c0.6,0,1.2,0.5,1.2,1.2v10%20C23.7,21.7,23.2,22.3,22.6,22.3z%20M9.4,10.8c-0.1,0-0.3,0.1-0.3,0.3v10c0,0.1,0.1,0.3,0.3,0.3h13.1c0.1,0,0.3-0.1,0.3-0.3v-10%20c0-0.1-0.1-0.3-0.3-0.3H9.4z'/%3e%3c/g%3e%3c/g%3e%3cpath%20style='&st5;'%20d='M16,30.2C8.2,30.2,1.8,23.8,1.8,16S8.2,1.8,16,1.8S30.2,8.2,30.2,16S23.8,30.2,16,30.2z%20M16,2.8%20C8.7,2.8,2.8,8.7,2.8,16S8.7,29.2,16,29.2S29.2,23.3,29.2,16S23.3,2.8,16,2.8z'/%3e%3c/g%3e%3c/svg%3e)
Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Funding News
10/21/2026
FundingGene TherapyNewsletterRetinaThyroid Eye Disease
City Therapeutics Leads Latest Fundraising with $230 Million IPO
City Therapeutics led recent ophthalmic fundraising efforts with a $230 million upsized initial public offering to advance its candidates for GA and Stargardt. Financing announced in the past four ...
10/21/2026
BiosimilarsCell TherapyChinaClinical TrialCornealDealsDiagnosticFundingGene TherapyGlaucomaIndustryMyopiaNewsletterOptometryRegulationRetinaSurgical
October 2026 Ophthalmic News Briefs
Sagent Pharmaceuticals, of Schaumburg, Illinois, announced Sept. 22 the US launch of Zyogreen, the first FDA-approved ready-to-use indocyanine green (ICG) injection in the US. Sagent said conventio...
9/25/2026
BreakingFundingRetinaStudy
€1 Million Champalimaud Vision Award in 2026 Goes to Botond Roska and José-Alain Sahel
The winners of the 2026 António Champalimaud Vision Award are researchers Botond Roska, MD, PhD, of Switzerland, and José-Alain Sahel, MD, of France and the US, for their pioneering optogenetic the...
9/22/2026
CornealDealsDry EyeFundingNewsletterPharmaPresbyopiaRefractiveRetina
Ingenia Leads Latest Fundraising with $42.3 Million Initial Public Offering
Ingenia Therapeutics led recent ophthalmic fundraising efforts, which totaled $57.3 million in the past four weeks.
9/18/2026
BreakingFundingRetina
Foundation Fighting Blindness Renames Venture Arm as Gund Vision Fund
The Foundation Fighting Blindness, of Columbia, Maryland, reported Sept. 10 that it had renamed its venture philanthropy arm the Gund Vision Fund. The fund was formerly called the Retinal Degenerat...
8/20/2026
DealsFundingNewsletter
AI Funding Boom Reshapes Venture Capital as Ophthalmology Investment Holds Steady
Record venture capital investment in the first half of 2026 was driven by artificial intelligence (AI) mega-rounds, while ophthalmology continued to draw steady investor interest. AI dominated H1-2...
8/20/2026
CataractChinaClinical TrialCornealDealsDiagnosticDry EyeFundingGene TherapyGlaucomaIOLNewsletterPharmaRetinaSurgical
Tarsus Leads Latest Fundraising with $125 Million Private Placement
Tarsus Pharmaceuticals led recent ophthalmic fundraising efforts with a $125 million private placement for clinical development and commercial activities. Financing announced in the past four weeks...
8/7/2026
BreakingFundingGlaucomaPharmaRegulation
Nicox Partner Kowa Submits NDA to US FDA for Glaucoma Drop
France’s Nicox announced July 1 that its partner Kowa, of Japan, had submitted a new drug application to the US FDA for NCX 470, also known as K-911, a nitric oxide-donating bimatoprost eye drop ca...
7/21/2026
BiosimilarsCornealDiagnosticDry EyeFundingGene TherapyNewsletterRetina
Ollin Leads Latest Fundraising with $330 Million in Series B Financing
Ollin Biosciences led recent ophthalmic fundraising efforts with $330 million in a Series B round to advance its candidates for retinal and thyroid eye disease. Financing announced in the past four...
6/18/2026
FundingGlaucomaNewsletterPharmaRetinaSurgicalThyroid Eye Disease
Ethyreal Bio Leads Latest Fundraising with $101 Million in Series A
Ethyreal Bio led recent ophthalmic fundraising efforts with $101 million in a Series A financing to advance its subcutaneous candidate for thyroid eye disease. Financing announced in the past four ...
6/18/2026
AIClinical TrialDealsEyeceleratorFundingMeetingNewsletterRegulation
Eyecelerator@ARVO and All Access Saturday Look at Business Side of Developing Therapeutics
May 1 marked the start of a new era for Eyecelerator, the organizer of ophthalmology innovation business conferences. It was the first time Eyecelerator was officially part of ARVO (Association for...
6/18/2026
FundingNewsletterOptometry
Georgia Southern University Gains Funding for State’s First College of Optometry
Georgia Southern University announced May 26 that it had received $29.8 million in state funding to establish the first college of optometry in Georgia. The school said the money will support the r...
6/5/2026
BreakingFundingOptometry
Georgia Southern University Gains Funding for State’s First College of Optometry
Georgia Southern University announced May 26 that it had received $29.8 million in state funding to establish the first college of optometry in Georgia. The school said the money will support the r...
5/14/2026
FundingGene TherapyNewsletterPharmaRetinaThyroid Eye Disease
Viridian Leads Latest Fundraising with $250 Million in Public Offerings
Viridian Therapeutics led recent ophthalmic fundraising efforts with $250 million in public offerings of convertible notes and Series B stock to advance its TED candidates. Financing announced in t...
5/14/2026
FundingGene TherapyNewsletterRetina
Inventors of Luxturna Win $3 Million Breakthrough Prize
Penn Medicine’s Jean Bennett, MD, PhD, and Albert Maguire, MD, along with Katherine High, MD, of Children’s Hospital of Philadelphia (CHOP), have been awarded a prestigious Breakthrough Prize in Li...
4/24/2026
BreakingFundingGene TherapyRetina
Inventors of Luxturna Win $3 Million Breakthrough Prize
Penn Medicine’s Jean Bennett, MD, PhD, and Albert Maguire, MD, along with Katherine High, MD, of Children’s Hospital of Philadelphia (CHOP), have been awarded a prestigious Breakthrough Prize in Li...
4/21/2026
AcquisitionsDealsFundingNewsletter
Fundraising Slows in Q1-2026 for Ophthalmic Firms
Market Scope identified 17 ophthalmic deals in Q1-2026, down from 21 in Q1-2025. Fundraising totals reached $856.6 million, a decline from $930.2 million in Q1-2025. The number of deals was below t...
4/21/2026
DeviceFundingIndustryNewsletterPharma
J&J Continues to Reduce JLABS Footprint with Exit from New York
Johnson & Johnson is stepping away from its JLABS incubator site in New York, reducing its JLABS locations in the US to those in San Diego, San Francisco, and Boston. The New York site opened in 20...
4/3/2026
BreakingChinaFundingStudy
China Gaining on US for Leadership in Early-Stage Drug Development, Georgetown Researchers Report
Early-stage drug development has increased dramatically over the past decade, with China gaining the most ground and challenging the US for leadership, according to Georgetown University. Georgetow...
3/27/2026
BreakingDeviceFundingIndustryPharma
J&J Continues to Reduce JLABS Footprint with Exit from New York
Johnson & Johnson is stepping away from its JLABS incubator site in New York, reducing its JLABS locations in the US to those in San Diego, San Francisco, and Boston. The New York site opened in 20...
3/24/2026
DeviceDiagnosticFundingGene TherapyGlaucomaNewsletterOculomicsRetinaSurgical
Science Corp. Leads Latest Fundraising with $230 Million in Series C
Science Corporation led recent ophthalmic fundraising efforts with $230 million in a Series C round to support its Prima implant for dry age-related macular degeneration. Financing announced in the...
3/24/2026
BiosimilarsCataractClinical TrialCornealDealsDiagnosticEuropeFundingGlaucomaIOLIndustryNewsletterPresbyopiaRefractiveRegulationRetinaStudySurgical
March 2026 Ophthalmic News Briefs
STAAR Surgical announced Feb. 17 that the US FDA had approved an expanded age indication for Evo and Evo+ implantable Collamer lenses (ICLs), extending their use from patients 21 to 45 years old to...
3/20/2026
BreakingDiagnosticFundingOculomicsStudy
Amydis Wins $2.5 Million NIH Grant to Advance Retinal Tracer for ALS
Amydis, of San Diego, California, announced March 11 that it had been awarded $2.5 million from the National Institutes of Health (NIH) to advance a retinal tracer that could foster earlier detecti...
3/13/2026
BreakingCataractFundingIndiaSurgical
Aravind Eye Surgeons Named as 2026 Chang-Crandall Humanitarian Award Recipients
The ASCRS Foundation Board announced Feb. 5 that it had selected Aravind Haripriya, MD, and Rengaraj Venkatesh, MD, as the recipients of its 2026 Chang-Crandall Humanitarian Award. The honor was es...
3/13/2026
BreakingFundingGlaucomaStudy
Glaucoma Research Foundation Awards Record $3.06 Million in Annual Research Grants
The Glaucoma Research Foundation announced March 9 that it would distribute a record total of $3.06 million in annual research grants to support innovative research in glaucoma and neurodegeneratio...
3/6/2026
BreakingCell TherapyFundingGene TherapyRetina
Cirrus Expands to Singapore, Unveils GA Cell Therapy Candidate
Cirrus Therapeutics reported March 3 that it had established an R&D site in Singapore, expanding its presence in the Asia-Pacific region. The Cambridge, Massachusetts, company also unveiled a secon...
2/23/2026
Cell TherapyCornealDealsDry EyeFundingGene TherapyIndiaNewsletterPresbyopiaRetina
BioAge Leads Latest Ophthalmic Fundraising with $115 Million Offering
BioAge led recent ophthalmic fundraising efforts with a $115 million upsized public offering to advance an oral treatment candidate for DME. Financing announced in the past four weeks totaled $308....
1/30/2026
BreakingFundingPresbyopiaRegulation
US FDA Approves Tenpoint’s Yuvezzi Drops for Presbyopia
Tenpoint Therapeutics announced Jan. 28 that the US FDA had approved Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution 2.75%/0.1%) for presbyopia. The company said it expects to launc...
1/21/2026
AcquisitionsDealsFundingNewsletter
Venture Capital in Ophthalmology Doubled in 2025 to Just Under $2 Billion
Venture capital investment in ophthalmology more than doubled from 2024 to 2025, totaling just under $2 billion in 2025 compared to $934.1 million in 2024. 2025 saw $1.1 billion in early-stage fund...
1/23/2026
BreakingEmergingFundingPharmaRetina
BioAge Enters Ophthalmology with Oral NLRP3 Inhibitor Candidate for DME
BioAge Labs announced Jan. 20 that it would expand development of BGE-102, an orally administered NLRP3 inhibitor, into ophthalmology with a proof-of-concept study in diabetic macular edema (DME). ...
1/21/2026
ChinaFundingGene TherapyNewsletterRetina
Kodiak Leads Latest Ophthalmic Fundraising with $184 Million Offering
Kodiak Sciences led recent ophthalmic fundraising efforts with a $184 million public offering to advance its Phase III candidates for retinal disease. Financing announced in the past four weeks tot...
12/16/2025
CornealDry EyeFundingNewsletterRetina
Belite Leads Latest Ophthalmic Fundraising with $350 Million Offering
Belite Bio led recent ophthalmic fundraising efforts with a $350 million offering to prepare for commercial-ization of oral tinlarebant for geographic atrophy and Stargardt. Financing announced in ...
11/19/2025
Dry EyeFundingGene TherapyGlaucomaNewsletterRetina
AAVantgarde Leads Latest Ophthalmic Fundraising with $141 Million in Series B
AAVantgarde Bio led recent ophthalmic fundraising efforts with $141 million in Series B funding to advance its retinal gene therapy pipeline. Financing announced in the past four weeks totaled $488...
10/23/2025
DealsFundingNewsletterPharmaRetina
Retinal Pharma Deals Drive Ophthalmic Fundraising in Q3-2025
The retinal pharmaceuticals sector was the most active for ophthalmic deals in Q3-2025 and accounted for $503.1 million. Across all ophthalmic sectors, we identified 16 transactions totaling $716.1...
10/23/2025
Cell TherapyCornealDiagnosticDry EyeFundingGene TherapyGlaucomaMyopiaNewsletterPharmaRetina
Ocular Tx Leads Latest Ophthalmic Fundraising with $475 Million Offering
Ocular Therapeutix led recent ophthalmic fundraising efforts with a $475 million underwritten public offering to advance its Axpaxli IVT implant candidate for retinal disease. Financing announced i...
10/17/2025
BreakingCornealDealsDiagnosticFunding
Epion Therapeutics Forms Strategic Partnership with Oculus
Epion Therapeutics announced Oct. 7 that it had entered a strategic partnership with Germany’s Oculus, maker of the Pentacam corneal tomographer. The partnership comes in conjunction with Epion clo...
10/10/2025
BreakingFundingRetinaStudy
Teresa Puthussery, PhD, OD, Named 2025 MacArthur Fellow
Teresa Puthussery, PhD, a neurobiologist and optometrist, has been named one of the 22 MacArthur Fellows for 2025. The MacArthur Foundation, based in Chicago, Illinois, annually selects fellows who...
9/26/2025
BreakingFundingGene TherapyMyopiaRetinaStudy
NEI Awards U. of Houston Researchers $3.6 Million to Investigate Vision-Critical Gene
A research team at the University of Houston was awarded more than $3.6 million from the National Eye Institute to investigate a gene that causes blinding retinal diseases when mutated. When workin...
9/22/2025
AICell TherapyCornealDealsDigitalFundingGene TherapyGlaucomaNewsletterRetinaSurgicalThyroid Eye Disease
Kriya Leads Latest Ophthalmic Fundraising with $320 Million in Series D
Kriya, of Durham, North Carolina, led recent ophthalmic fundraising efforts with a $320 million Series D round to fund its pipeline of gene therapy candidates. Financing announced in the past four ...
9/22/2025
BiosimilarsClinical TrialCornealDealsDiagnosticDry EyeEuropeFundingGene TherapyGlaucomaIndustryNewsletterRefractiveRegulationRetinaSurgical
September 2025 Ophthalmic News Briefs
The UK-based National Institute for Health and Care Excellence (NICE) announced Sept. 11 that it had approved idebenone (marketed as Raxone by Chiesi Pharmaceuticals) for the treatment of Leber her...
9/19/2025
BreakingCataractFundingSurgical
€1 Million Champalimaud Vision Award Goes to Three Prominent Eye Charities
The winners of the 2025 António Champalimaud Vision Award are the Fred Hollows Foundation; Lions Clubs International Foundation (LCIF) with its SightFirst program; and the International Agency for ...
9/5/2025
BreakingFundingRetina
LambdaVision Secures NASA Award to Advance Manufacturing of Artificial Retina in Low-Earth Orbit
LambdaVision announced Sept. 4 that it had secured an award from the National Aeronautics and Space Administration (NASA) to further develop the low-Earth orbit manufacturing process for its artifi...
8/29/2025
BreakingFundingOptometryRefractive
Eyebot to Expand Self-Serve Vision-Testing Kiosks with $20 Million Financing
Eyebot, of Boston, Massachusetts, plans to use the $20 million it raised in a Series A round in August 2025 to expand its vision testing kiosks to new retail locations. The kiosks—located in malls,...
8/29/2025
BreakingFundingGlaucomaStudy
Glaucoma Research Foundation to Use $5 Million Gift to Create Accelerator
The Glaucoma Research Foundation reported Aug. 20 that it plans to use a $5 million gift from the John and Daria Barry Foundation—the largest single donation in the foundation’s history—to launch t...
8/20/2025
FundingGene TherapyNewsletterRetina
Ocugen Leads Latest Ophthalmic Fundraising with $20 Million Offering
Ocugen led recent ophthalmic fundraising efforts with a $20 million registered direct offering to advance its clinical gene therapy pipeline in retina. Financing announced in the past four weeks to...
8/20/2025
DealsFundingNewsletterRetina
Boehringer Ingelheim and Re-Vana Sign Potential $1 Billion Collaboration Deal
Boehringer Ingelheim and Re-Vana Therapeutics will collaborate to develop extended-release therapies for eye diseases in a deal worth potentially more than $1 billion for Re-Vana, the companies ann...
8/20/2025
FundingNewsletterStudy
Eye Physicians, Researchers Band Together to Stave Off NEI Cuts
The American Academy of Ophthalmology (AAO) announced July 23 that it had joined with other professional and vision research organizations to fight proposed funding cuts and consolidation threats a...
8/8/2025
BreakingFundingRegulationStudy
Eye Physicians, Researchers Band Together to Stave Off NEI Cuts, Consolidation
The American Academy of Ophthalmology (AAO) announced July 23 that it had joined with other professional and vision research organizations to fight proposed funding cuts and consolidation threats a...
7/22/2025
AcquisitionsDealsFundingNewsletter
Ophthalmic Venture Capital Continues to Bounce Back, Driven by Retinal Pharma
Venture capital investments accounted for 96 percent of ophthalmic deals in Q2-2025, with financing rounds totaling $590.7 million—the highest quarter since Q3-2023, when these transactions reached...
7/22/2025
AICataractFundingGene TherapyGlaucomaNewsletterPharmaRetinaSurgical
ForSight Leads Latest Ophthalmic Fundraising with $125 Million in Series B
Israel’s ForSight Robotics led recent ophthalmic fundraising efforts with $125 million in Series B funding as it prepares its robotic cataract surgery system for human trials. Financing announced i...
7/22/2025
BiosimilarsCataractCell TherapyChinaClinical TrialDealsDiagnosticDry EyeEuropeFundingFundusGene TherapyGlaucomaNewsletterPharmaPresbyopiaRegulationRetinaSurgical
July 2025 Ophthalmic News Briefs
Hoya Vision Care announced June 2 that it had acquired Centennial Optical, a Canadian distributor of ophthalmic frames, eyeglass lenses, sunglasses, lab supplies, and optical accessories. Financial...
7/3/2025
BreakingCataractFundingGlaucomaRetinaStudy
Donor Gives $40M to Ophthalmology Department at CU Anschutz in Colorado
An anonymous donor has given a $40 million gift for eye research to the Department of Ophthalmology at the University of Colorado (CU) AnschutzMedical Campus in Aurora, Colorado, the school announc...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.